Horizon Technology Finance Corp  

(Public, NASDAQ:HRZN)   Watch this stock  
Find more results for Dan Michaud
14.08
+0.06 (0.43%)
Mar 6 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.02 - 14.18
52 week 12.17 - 15.07
Open 14.11
Vol / Avg. 21,823.00/22,110.00
Mkt cap 135.89M
P/E 17.35
Div/yield 0.12/9.80
EPS 0.81
Shares 9.63M
Beta 0.44
Inst. own 22%
Mar 11, 2015
Q4 2014 Horizon Technology Finance Corp Earnings Call - 9:00AM EDT - Add to calendar
Mar 10, 2015
Q4 2014 Horizon Technology Finance Corp Earnings Release - 4:00PM EDT - Add to calendar
Jan 22, 2015
Horizon Technology Finance Corp Extraordinary Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 51.19% 14.69%
Operating margin 51.62% 15.70%
EBITD margin - 15.70%
Return on average assets 7.92% 1.39%
Return on average equity 13.87% 2.50%
CDP Score - -

Address

312 Farmington Ave
FARMINGTON, CT 06032-1913
United States - Map
+1-860-6768654 (Phone)
+1-860-6768655 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Horizon Technology Finance Corporation is a closed-end, non-diversified management investment company. The Company�s investment objective is to generate current income from the loans it makes and capital appreciation from the warrants it receives when making such loans. It makes secured loans (venture loans) to companies backed by established venture capital and private equity firms in its target industries (venture lending). Horizon Technology Finance Management LLC is the advisor of the Company. In December 2013, the Company announced in connection with the sale of substantially all of the assets of ACT Biotech, Inc, the Company has successfully settled its investment in ACT Biotech, Inc.

Officers and directors

Robert D. Pomeroy Jr. Chairman of the Board, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Gerald A. Michaud President, Director
Age: 60
Bio & Compensation  - Reuters
Christopher M. Mathieu Senior Vice President, Chief Financial Officer and Treasurer
Age: 48
Bio & Compensation  - Reuters
John C. Bombara Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
Age: 50
Bio & Compensation  - Reuters
Dan S. Devorsetz Senior Vice President, Chief Credit Officer
Age: 43
Bio & Compensation  - Reuters
Christopher B. Woodward Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
James J. Bottiglieri Independent Director
Age: 57
Bio & Compensation  - Reuters
Edmund V. Mahoney Independent Director
Age: 63
Bio & Compensation  - Reuters
Elaine A. Sarsynski Independent Director
Age: 58
Bio & Compensation  - Reuters